Published in Arch Virol on January 01, 1997
Detection of feline leukemia virus RNA in saliva from naturally infected cats and correlation of PCR results with those of current diagnostic methods. J Clin Microbiol (2006) 0.96
Development and application of a quantitative real-time PCR assay to detect feline leukemia virus RNA. Vet Immunol Immunopathol (2008) 0.84
Evidence of horizontal transmission of feline leukemia virus by the cat flea ( Ctenocephalides felis). Parasitol Res (2003) 0.80
Molecular detection, phylogenetic analysis, and identification of transcription motifs in feline leukemia virus from naturally infected cats in malaysia. Vet Med Int (2014) 0.78
Acute monoblastic leukemia in a FeLV-positive cat. J Vet Sci (2008) 0.75
Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias. Nature (1984) 2.14
Comparison of six in-house tests for the rapid diagnosis of feline immunodeficiency and feline leukaemia virus infections. Vet Rec (2001) 2.08
Horizontal transmission of leukemia virus and leukemia in the cat. J Natl Cancer Inst (1973) 2.00
The frequency of occurrence of feline leukaemia virus subgroups in cats. Int J Cancer (1978) 1.66
Determinants of the host range of feline leukaemia viruses. J Gen Virol (1973) 1.64
Biology of feline leukemia virus in the natural environment. Cancer Res (1976) 1.59
Relationship among Lewis phenotype, clotting factors, and other cardiovascular risk factors in young adults. J Lab Clin Med (1995) 1.46
Feline leukemia virus envelope gp70 of subgroups B and C defined by monoclonal antibodies with cytotoxic and neutralizing functions. J Immunol (1983) 1.44
Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United Kingdom. Vet Rec (1989) 1.43
Vaccination against feline leukaemia virus. Vet Rec (1994) 1.39
Persistence and transmission of natural type I feline coronavirus infection. J Gen Virol (2003) 1.36
Replication of cat leukemia virus in cell cultures. Nature (1968) 1.34
Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes. J Gen Virol (1992) 1.33
Productive infection of T-helper lymphocytes with feline immunodeficiency virus is accompanied by reduced expression of CD4. AIDS (1991) 1.33
Feline leukemia-virus infection of kittens: mortality associated with atrophy of the thymus and lymphoid depletion. J Natl Cancer Inst (1971) 1.25
Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route. Immunology (1991) 1.25
Isolation of the nucleic acid of feline leukemia virus. Virology (1971) 1.25
A study of naturally occurring feline coronavirus infections in kittens. Vet Rec (1992) 1.24
Induction of protective immune response in cats by vaccination with feline leukemia virus iscom. J Immunol (1985) 1.22
Differential growth and transmission in cats of feline leukaemia viruses of subgroups A and B. Int J Cancer (1978) 1.21
Infection with feline immunodeficiency virus is followed by the rapid expansion of a CD8+ lymphocyte subset. Immunology (1993) 1.17
A monoclonal antibody which blocks infection with feline immunodeficiency virus identifies a possible non-CD4 receptor. J Virol (1993) 1.15
Serological responses of cats to feline immunodeficiency virus. AIDS (1990) 1.14
Selective effect of feline leukaemia virus on early erythroid precursors. Nature (1982) 1.12
Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. J Virol (1995) 1.11
Interaction between feline leukaemia virus subgroups in the pathogenesis of erythroid hypoplasia. Int J Cancer (1984) 1.10
Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9. Immunology (1994) 1.09
Use of a reverse-transcriptase polymerase chain reaction for monitoring the shedding of feline coronavirus by healthy cats. Vet Rec (2001) 1.09
Immunodiagnosis of feline immunodeficiency virus infection using recombinant viral p17 and p24. AIDS (1991) 1.08
Virus neutralization reveals antigenic variation among feline immunodeficiency virus isolates. J Gen Virol (1994) 1.06
Viral oncogenesis: lessons from naturally occurring animal viruses. Cancer Surv (1987) 1.05
Vaccination against feline leukaemia virus using a cell membrane antigen system. Int J Cancer (1975) 1.04
Anemia associated with feline leukemia virus infection in cats. J Natl Cancer Inst (1975) 1.03
Enhancement after feline immunodeficiency virus vaccination. Vet Immunol Immunopathol (1992) 1.03
Horizontal transmission of feline leukemia virus under natural conditions in a feline leukemia cluster household. Int J Cancer (1977) 1.02
Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL. J Virol (1993) 1.01
DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies. J Virol (1998) 1.01
Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination. J Immunol (1996) 1.00
Detection of transient and persistent feline leukaemia virus infections. Vet Rec (1982) 1.00
A comparison of DNA amplification, isolation and serology for the detection of Chlamydia psittaci infection in cats. Vet Rec (1998) 1.00
A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction. J Virol (1996) 0.99
Feline oncornavirus-associated cell membrane antigen. IV. Antibody titers in cats with naturally occurring leukemia, lymphoma, and other diseases. J Natl Cancer Inst (1975) 0.99
Clinical and pathological findings in feline immunodeficiency virus experimental infection. Vet Immunol Immunopathol (1992) 0.99
Long-term impact on a closed household of pet cats of natural infection with feline coronavirus, feline leukaemia virus and feline immunodeficiency virus. Vet Rec (2000) 0.98
Polypeptides of feline leukemia virus: a glycosylated gag-related protein is released into culture fluids. Virology (1980) 0.98
Histologic classification and immunophenotype of lymphosarcomas in cats with naturally and experimentally acquired feline immunodeficiency virus infections. Vet Pathol (1996) 0.98
Feline viruses in wildcats from Scotland. J Wildl Dis (1999) 0.95
Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus. J Virol (2000) 0.95
Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus. AIDS Res Hum Retroviruses (1995) 0.94
Suppression of virus burden by immunization with feline immunodeficiency virus Env protein. Vaccine (1996) 0.94
Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors. J Virol (2001) 0.93
Induction of feline immunodeficiency virus-specific cell-mediated and humoral immune responses following immunization with a multiple antigenic peptide from the envelope V3 domain. Immunology (1995) 0.92
Antibodies in normal and leukemic cats to feline oncornavirus-associated cell membrane antigens. J Natl Cancer Inst (1973) 0.92
Lymphosarcoma in experimentally induced feline immunodeficiency virus infection [corrected]. Vet Rec (1992) 0.92
Growth of feline leukaemia virus in human cells. Nature (1969) 0.91
Value of alpha 1-acid glycoprotein in the diagnosis of feline infectious peritonitis. Vet Rec (1997) 0.91
An electron microscopic study of virus particles in spontaneous leukemia in the cat. J Natl Cancer Inst (1968) 0.91
A comparison of three methods of feline leukaemia virus diagnosis. Vet Rec (1982) 0.90
The basis of the tumorigenicity of BHK 21 cells. Int J Cancer (1968) 0.90
Feline leukaemia virus: protective immunity is mediated by virus-specific cytotoxic T lymphocytes. Immunology (2000) 0.90
An improved assay for feline leukaemia virus pseudotypes of murine sarcoma virus. J Gen Virol (1976) 0.90
Transmission of feline leukaemia virus in the milk of a non-viraemic cat. Vet Rec (1986) 0.89
Haemopoietic colony formation (BFU-E, GM-CFC) during the development of pure red cell hypoplasia induced in the cat by feline leukaemia virus. Leuk Res (1983) 0.89
Immunogenicity of a peptide from a major neutralising determinant of the feline immunodeficiency virus surface glycoprotein. Vaccine (1996) 0.89
Dynamics of viral and proviral loads of feline immunodeficiency virus within the feline central nervous system during the acute phase following intravenous infection. J Virol (2003) 0.89
Serological analysis of feline calicivirus isolates from the United States and United Kingdom. Vet Microbiol (1997) 0.88
Antibody response and virus survival in cats vaccinated against feline leukaemia. Nature (1974) 0.88
Polyclonal B-cell activation in cats infected with feline immunodeficiency virus. Immunology (1994) 0.87
Effect of hydrocortisone on osteoclasts generated in cat bone marrow cultures. Calcif Tissue Int (1983) 0.87
Detection of feline leukemia virus infection in saliva. J Clin Microbiol (1987) 0.86
The specificity of neutralizing antibodies to feline leukaemia viruses. Int J Cancer (1978) 0.86
Feline leukaemia (lymphosarcoma) symposium. 2. Experimental studies in feline leukaemia. J Small Anim Pract (1969) 0.85
Restricted host range of a feline leukaemia virus. Nature (1972) 0.85
Factors influencing cellular immune responses to feline immunodeficiency virus induced by DNA vaccination. Vaccine (2000) 0.85
Different transplantation antigens in BHK21 cells transformed by four strains of polyoma virus. Virology (1966) 0.84
Recovery of feline leukaemia virus from non-viraemic cats. Vet Rec (1983) 0.84
Polypeptides of feline leukaemia virus: identification of p15(E) and p12(E). J Gen Virol (1980) 0.84
Serological responses in cats vaccinated with FeLV ISCOM and an inactivated FeLV vaccine. Vaccine (1989) 0.84
Comparative efficiency of feline immunodeficiency virus infection by DNA inoculation. AIDS Res Hum Retroviruses (1997) 0.84
Transmission of feline immunodeficiency virus from mother to kitten. Vet Rec (1991) 0.84
Protection of kittens from feline leukaemia virus infection by maternally-derived antibody. Vet Rec (1977) 0.84
Limited efficacy of an inactivated feline immunodeficiency virus vaccine. Vet Rec (2006) 0.84
Suppression of feline immunodeficiency virus replication in vitro by a soluble factor secreted by CD8+ T lymphocytes. Immunology (1999) 0.84
Virology and host range of feline leukemia virus. J Am Vet Med Assoc (1971) 0.84
Are endogenous feline leukemia viruses really endogenous? Vet Immunol Immunopathol (2011) 0.83
The occurrence of feline leukaemia virus neutralizing antibodies in cats. Int J Cancer (1978) 0.83
Decreased mitogen responsiveness and elevated tumor necrosis factor production in cats shortly after feline immunodeficiency virus infection. Vet Immunol Immunopathol (1992) 0.83
Cytokine production by cats infected with feline immunodeficiency virus: a longitudinal study. Immunology (1995) 0.82
Protection against oronasal challenge with virulent feline leukaemia virus lasts for at least 12 months following a primary course of immunisation with Leukocell 2 vaccine. Vaccine (2002) 0.82
Duration of the latent state in feline leukaemia virus infections. Vet Rec (1985) 0.81
B and T cells in a cat with thymic lymphosarcoma. J Natl Cancer Inst (1975) 0.81
The generation of monoclonal antibodies recognising novel epitopes by immunisation with solid matrix antigen-antibody complexes reveals a polymorphic determinant on feline CD4. J Immunol Methods (1994) 0.81
Replication of leukemogenic-type virus in cats inoculated with feline lymphosarcoma extracts. J Natl Cancer Inst (1968) 0.80
Feline immunodeficiency virus (FIV)-associated lymphoma: a potential role for immune dysfunction in tumourigenesis. Vet Immunol Immunopathol (1998) 0.80
Analysis of the protective immunity induced by feline immunodeficiency virus vaccination. Adv Vet Med (1999) 0.79
Feline calicivirus induced polypeptides. Microbios (1980) 0.79
Prevalence of specific anti-Cryptosporidium IgG, IgM and IgA antibodies in cat sera using an indirect immunofluorescence antibody test. Vet Parasitol (1995) 0.79
Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats, but does not confer protection. J Virol (1997) 0.78
A possible maturation pathway of calicivirus particles. Microbios (1986) 0.78
Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene. Vaccine (1993) 0.78